Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?

被引：2
|
作者：
Kraenzlin, Marius E. [1 ]
Meier, Christian [1 ]
机构：
[1] Univ Basel Hosp, Div Endocrinol Diabet Clin Nutr, CH-4055 Basel, Switzerland
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2007年 / 3卷 / 10期
关键词：
alendronate; BMD; bone turnover; nonvertebral fracture; vertebral fracture;
D O I：
10.1038/ncpendmet0618
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：686 / 687
页数：2
相关论文
共 50 条
  • [41] Serum testosterone does not affect bone mineral density in postmenopausal women
    Arpaci, Dilek
    Saglam, Fatma
    Cuhaci, Fatma Neslihan
    Ozdemir, Didem
    Ersoy, Reyhan
    Cakir, Bekir
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (04): : 292 - 296
  • [42] DOES OBESITY INFLUENCE BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN IN THE UAE?
    Adams, B. K.
    Parkar, S.
    Kalla, A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S713 - S714
  • [43] Thyroid Dysfunction Does Not Affect the Bone Mineral Density in Postmenopausal Women
    Deniz, HaticeCeyda
    Keskin, Huseyin Levent
    Secen, Elcin Islek
    Akcay, Gulin Feykan Yegin
    Ustuner, Isik
    Avsar, Ayse Filiz
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2014, 5 (01) : 25 - 28
  • [44] Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis?
    Gallagher, J. Christopher
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (03): : 128 - 129
  • [45] Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis?
    J Christopher Gallagher
    Nature Reviews Endocrinology, 2009, 5 : 128 - 129
  • [46] PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass
    Zhao, Jiao
    Liu, Li
    Lv, Shanshan
    Wang, Chun
    Yue, Hua
    Zhang, Zhenlin
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 1669 - 1678
  • [47] Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study
    Hejdova, M
    Palicka, V
    Kucera, Z
    Vlcek, J
    PHARMACY WORLD & SCIENCE, 2005, 27 (03): : 149 - 153
  • [48] Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study
    Miroslava Hejdova
    Vladimir Palicka
    Zdenek Kucera
    Jiri Vlcek
    Pharmacy World and Science, 2005, 27 : 149 - 153
  • [49] DENOSUMAB FOLLOWING LONG-TERM ALENDRONATE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude-Laurent
    Brown, Jacques P.
    Lillestol, Mike
    Siddhanti, Suresh
    Man, Hoi-Shen
    San Martin, Javier
    Bone, Henry G.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S215 - S215
  • [50] Early Effects of Denosumab in Postmenopausal Women with Low Bone Mineral Density Previously Treated with Alendronate
    Brown, J. P.
    Kendler, D. L.
    Benhamou, C. L.
    Lillestol, M.
    Roux, C.
    Siddhanti, S.
    Man, H. S.
    Martin, J. San
    Bone, H. G.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3973 - 3974
12345